Lawmakers Advocate for Increased Defense Biotech Research Amid China’s Pursuit of InnovationsU.S. Biotechnology Development: A National Security Imperative
Washington, D.C.,
October 10, 2025
Originally published in DEFCROS News
U.S. Biotechnology Development: A National Security ImperativeThe Growing Challenge from ChinaSenator Todd Young (R-Ind.) voiced urgent concerns regarding the United States’ lagging position in biotechnology innovation. He emphasized the need for increased focus on biotechnological advancements, particularly in military applications, as China continues to integrate advanced technologies, including gene editing, to enhance soldier performance on the battlefield. As the Trump administration reduced funding for scientific research, Young and other lawmakers underscore biotechnology not only as a crucial component of national security but also as an economic catalyst for regions they represent. Strategic Investment RecommendationsDuring a recent event hosted by the With Honor Institute, Senator Young highlighted specific areas where China excels, notably in biomanufacturing and the industrial application of biotechnology. This includes the development of innovative materials and life-saving compounds that hold significant utility for military personnel. An April report by Young’s National Security Commission on Emerging Biotechnology outlined 49 strategic recommendations aimed at leveraging biotechnology to bolster U.S. defense capabilities. Key insights from the report include:
Moreover, the report mentioned the potential for shelf-stable blood products that could dramatically improve combat lifesaving efforts and suggested the incorporation of biotechnological materials into weapon systems. Legislative Concerns and InitiativesCongressional apprehensions regarding cuts to science funding have intensified, particularly in light of a reported $4 billion reduction affecting universities, hospitals, and other research institutions. Representative Chrissy Houlahan (D-Pa.), a founder of the Biotechnology Caucus, expressed serious concerns about the implications of such funding reductions. She described the situation as having a “chilling effect” at both business and individual research levels. Houlahan stated, “If we aim to lead in manufacturing and technology, dismantling the foundational research underpinning these sectors is counterintuitive.” In response, Houlahan and her colleagues have embedded various biotechnology provisions within the latest National Defense Authorization Act. This includes a directive compelling the Department of Defense to develop a formal strategy for its biotechnology initiatives. Potential for Bipartisan SupportBoth Young and Houlahan noted the bipartisan enthusiasm surrounding the CHIPS and Science Act, a landmark piece of legislation aimed at enhancing U.S. technological independence. Young remarked, “The administration has demonstrated it can endorse industrial policy, especially if credited with the initiative.” He believes there exists a prime opportunity to establish a biotech program that would significantly benefit agricultural communities. The potential for biotechnology economic growth in states like Indiana is substantial. Young stressed that the administration campaigned on promises of renewed innovation and manufacturing, particularly appealing to often-overlooked rural demographics. He argued that failing to prioritize biotechnology could allow opposing parties to claim the narrative of championing rural America and biomanufacturing. Moving ForwardAs the Trump administration continues to reshape federal priorities, it is evident that a vigorous vision for advancing biotechnology is needed. The urgency for a strategic approach towards research and development in this sector is paramount not just for national defense, but also for economic resilience. In summary, focusing on biotechnology could fortify the U.S. military advantage, stimulate economic growth, and ensure the nation remains a competitive player in the global landscape of technology and innovation. |